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Despite the fact that rodents are considered to be the
infectious source of hantavirus for humans, another route
of transmission was demonstrated. Andes virus (ANDV)
has been responsible for most of the cases recorded in
Argentina. Person-to-person transmission of ANDV Sout
lineage was described during an outbreak of hantavirus
pulmonary syndrome in southwest Argentina. In this study,
we analyzed 4 clusters that occurred in 2 disease-endemic
areas for different ANDV lineages. We found new evidence
of interhuman transmission for ANDV Sout lineage and
described the first event in which another lineage, ANDV
Cent BsAs, was implicated in this mechanism of transmis-
sion. On the basis of epidemiologic and genetic data, we
concluded that person-to-person spread of the virus likely
took place during the prodromal phase or shortly after it
ended, since close and prolonged contact occurred in the
events analyzed here, and the incubation period was
15–24 days.
T
he genus Hantavirus is a growing group of rodent-
borne viruses of worldwide distribution that cause
human diseases. Hantavirus is the only genus of the fami-
ly  Bunyaviridae, which comprises rodentborne viruses.
Specific species of rodents are natural reservoirs for differ-
ent hantavirus types. In America, hantaviruses are mainly
carried by sigmodontine rodents. Hantavirus pulmonary
syndrome (HPS) was first described in North America in
1993 (1,2), and then reported in several other countries of
North, Central, and South America (3–9). Andes virus
(ANDV) was characterized in Argentina in 1995 on the
basis of specimens from a patient who died of HPS (3,10),
and Andes virus has been responsible for most HPS cases
recorded in Argentina, Chile, and Uruguay (7).
Six different ANDV lineages have been reported to
cause HPS in Argentina: ANDV Sout in the southwest
region; ANDV Cent BsAs, ANDV Cent Lec, and ANDV
Cent Plata in the central region; and ANDV Nort Orán and
ANDV Nort Bermejo in the northwest region. The defini-
tion of these 6 lineages was previously established on the
basis of nucleotide and amino acid differences (7,9).
Although rodents are considered to be the infectious
source for humans, another route of infection was demon-
strated. Viral person-to-person transmission of ANDV
Sout lineage was described for the first time during an HPS
outbreak in southwest Argentina in 1996, in which 16 per-
sons were involved (11–13), but in general, clusters of
HPS cases are mainly attributed to a common source of
rodent exposure. This mechanism of interhuman virus
spread, which makes ANDV unique among the hantavirus-
es, is not the only exclusive feature of this virus. ANDV
was the only American hantavirus isolated from human
serum (14). Most importantly, ANDV was shown to be
highly lethal in Syrian hamsters, and the characteristics of
the disease closely resembled HPS in humans (15). Similar
results have been recently obtained with Maporal virus
(16).
We analyzed 4 case clusters of hantavirus infection and
present new evidence for interhuman transmission of
ANDV Sout lineage. We also describe the first event in
which another lineage, ANDV Cent BsAs, has been impli-
cated in this rare but already proven route of transmission.
Materials and Methods
Study Population
Thirteen HPS cases that occurred during the second
half of 2002 in Argentina were analyzed in this study
(Table 1). Cases were grouped in 4 clusters (C1–C4)
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Samples from 12 of the 13 case-patients were available:
we collected serum and clot samples from almost all
patients; from patient C4-a, clot samples could not be
obtained; from patient C2-d1, a hemoculture was available
after death. A sample from the son in cluster 2 (C2-s) was
not available. Serologic confirmation was performed on 11
serum specimens and on the hemoculture samples as pre-
viously described (17).
Genetic Characterization
Ten clot samples and 1 serum sample were subjected to
viral detection methods as described (7). For viral genetic
characterization, a partial fragment of G2-encoding region
from the M segment was analyzed: genomic positions
2717–2943 (G2). For cases sharing 100% nucleotide iden-
tity in G2 fragment, 1 or 2 additional regions were ana-
lyzed: positions 66–434 from G1-encoding region (G1);
positions 1384–1795 for C4 and 1395–1809 for C1 from
the S-noncoding region (S-NCR). All fragments were
numbered in the antigenome-sense sequence relative to
ANDV. The new sequences used in this manuscript have
been submitted to GenBank (accession nos.
DQ189092–DQ189095). 
Results
Epidemiologic Findings
The cases were grouped into 4 clusters (Table 1), and
the approximate geographic locations of the exposure sites
are shown in Figure 1. Cluster 1 (C1) was a father-son pair
(C1-f and C1-s). The first patient, C1-f, was a previously
healthy veterinarian. He worked on a farm >65 km away
from his home. He began working there 40 days before the
onset of symptoms. He slept at the farm during the week
and returned to his home on weekends. The first manifes-
tation of his illness, abdominal pain and vomiting, began
on a Wednesday. On the Friday of that week, he exhibited
typical indistinguishable features of the prodromal phase.
The following weekend, he remained in his house with his
2 sons. Although he was very ill, his younger son slept
with him in the same bed; at that time, the prodromal phase
was ending, since on the next Monday he began to experi-
ence progressive dyspnea. He sought medical attention but
proceeded rapidly to pulmonary edema and shock. He died
on Wednesday. His 2 sons had never visited his place of
work, and they lived with their mother in another house in
the city of Buenos Aires. Epidemiologists from Buenos
Aires City reported that both houses were in urban areas,
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rodents. Twenty-four days after the last contact with his
sick father, fever developed in the younger son (C1-s)
(Figure 2). Once immunoglobulin M antibodies to han-
tavirus was confirmed, he was hospitalized. 
Cluster 2 (C2) was a rural cluster within a family of 5
that lived in a cabin. Rodent infestation of the house and
surrounding areas was evident. The onset of symptoms of
3 of the 4 case-patients occurred during a 12-day period
(Table 1). The mother in C2 (C2-m) began having symp-
toms when HPS was already confirmed in her 2 daughters
(C2-d1 and C2-d2), but she did not seek medical consulta-
tion until 5 days later, when she was hospitalized and died.
Cluster 3 (C3), a rural cluster composed of 4 friends
(cases C3-1 to C3-4), was similar to the previous cluster
since all became ill during a period of 20 days (Table 1).
They lived together in a cabin within the farm where they
worked. Rodent infestation of the house and surrounding
areas was also evident.
Cluster 4 (C4) involved a case-patient (C4-a) and a per-
son he came into contact with (C4-b), and a third person
who came into contact with C4-b. The index patient lived
and worked in Neuquén City, where neither HPS cases nor
rodent infestation had been registered. He traveled to Mar
del Plata in the province of Buenos Aires, 1,005 km north-
east of Neuquén City, where he remained for a few days
while attending a meeting. His first symptoms (fever and
myalgia) began before his return to Neuquén from Mar del
Plata, 23 days after he returned from a vacation in Villa La
Angostura, a small town surrounded by a wilderness area,
447 km southwest of Neuquén City (Figure 1). Two HPS
cases were reported in 2002, and several infected rodents
were captured previously. During the case-patient’s 14-
hour bus trip from Mar del Plata to Neuquén, he sat next a
man he did not know (C4-b). During the trip, a nonproduc-
tive cough, dyspnea, tachypnea, and headache developed,
and myalgia worsened. After their arrival in Neuquén,
patient C4-b helped patient C4-a with his luggage and
shared a taxicab with him. Patient C4-a was hospitalized
24 hours later. Patient C4-b spent 2 days in Neuquén (he
never left the city). Fifteen days after the 14-hour bus trip
to Neuquén City, patient C4-b became ill. He first experi-
enced weakness and myalgia; vomiting and diarrhea
developed 2 days later, and fever developed 6 days after
the onset of the first symptoms. C4-b met a friend and co-
worker (C4-c) 3 times during his prodromal phase; C4-c
visited C4-b while he was hospitalized (Figure 2).
Although C4-b did not have respiratory clinical symptoms,
the chest radiograph showed interstitial infiltrates and
Kurley B lines, and he had severe hypoxemia. The major
clinical manifestations were weakness, gastrointestinal ill-
ness, and myalgia. An epidemiologic investigation led cli-
nicians to suspect HPS. C4-c began to exhibit the first HPS
symptoms 22 days after C4-b. C4-c had never left the
province of Buenos Aires.
Viral Characterization
Nucleotide sequence comparisons of G2 fragment
between sequences from the 11 cases, 5 nonlinked (NL)
cases, and 5 previously published ANDV lineages are
shown in Table 2. Comparisons in each of the 4 clusters
showed 100% identity between cases in the same cluster.
ANDV Cent BsAs lineage was characterized from C1, C2
(2/4 cases), and C3, while ANDV Sout was characterized
from the 3 C4 cases, although C4-3 had never been to the
southwestern part of the country. The 3 clusters from La
Plata and NL-1 showed the highest similarity between
them and showed significant differences with HPS cases
from other places in Buenos Aires (Table 1).
Assessment of the Route of Transmission
Rodent transmission is the most common route of han-
tavirus infection. However, when a new HPS case is sus-
pected, if rodent exposure was not evident, for interhuman
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Figure 1. Location of residences and possible sites of exposure of
hantavirus pulmonary syndrome patients in the provinces of
Buenos Aires and Neuquén and Andes virus (ANDV)–endemic
regions, 2002.
Figure 2. Contact events and incubation period of hantavirus pul-
monary syndrome patients, Argentina, 2002. One line was drawn
per case for C1 and C4; dotted lines represent the incubation peri-
od since the established moment of contact between contiguous
case-patients. The onset of illness for each patient is indicated by
day 0. Triangles indicate contacts between patients. II indicates
day of death.transmission to be suspected, one must 1) find a epidemi-
ologic link with a previous case-patient (index case-
patient); 2) confirm 100% viral nucleotide identity with the
index patient in the fragments analyzed; and 3) assuming
that the secondary patient could have been exposed to
infectious rodents in the same or a different place than the
index patient, determine the probability that both viral
strains have 100% nucleotide identity in the fragments
analyzed.
In C1, only C1-f had an evident rodent exposure. The
only risk for C1-s was the close contact with C1-f during
his prodromal phase. In C4, only C4-a had an evident risk
of rodent transmission because he had visited a disease-
endemic area. The only risky activity of C4-b was close
contact with C4-a during the 14-hour bus trip. C4-c was in
contact with C4-b at several times after the latter returned
from Neuquén. All nucleotide fragment comparisons
showed 100% identity for G1, G2, and S-NCR for C1 and
C4. We analyzed viral variability in the areas of circulation
of AND Cent Bs As and ANDV Sout lineages by compar-
ing viral nucleotide sequences from previous HPS cases
and found a positive correlation between geographic dis-
tance and genetic distance for each ANDV lineage (data
not shown). Each ANDV lineage showed a significant
degree of variability between the supposed sites of expo-
sure in C1 for C1-f and C1-s and in C4 for C4-a and C4-b.
In summary, C1-s, C4-b, and C4-c were infected by inter-
human transmission.
Discussion
From July to December 2002, 31 HPS cases were
reported in Argentina, 13 of which were included in this
study because they occurred as linked cases grouped in 4
clusters. Three of these clusters occurred in the province of
Buenos Aires, where previous cases were isolated and spo-
radic (18). This is the first report of grouped HPS cases in
this province. In contrast, such an occurrence is not rare in
southern Argentina, where several clusters have been
detected since the first HPS case was described in 1995.
Three of these previous clusters occurred in the province
of Neuquén. In the present study, we described 3 events of
interhuman transmission: C1-f to C1-s, C4-a to C4-b, and
C4-b to C4-c. Besides the complete identity of the frag-
ments analyzed in each cluster, we conclude this mecha-
nism took place based on the following facts: for C1, only
C1-f was exposed to rodent infection in his work place (La
Plata), and C1-s did not visit C1-f’s work place. Similarly,
in C4, C4-a was the only one of the 3 case-patients with
epidemiologic risk of infection by rodent exposure during
his vacation in Villa La Angostura. C4-b spent 2 days in
Neuquén City, where HPS cases have never been reported.
C4-c, who never left the province of Buenos Aires, could
not have been infected by an endemic lineage from a place
1,300 km distant. Furthermore, 100% nucleotide identity
was found between the C4 strain and NL-2, which con-
firmed the hypothesis that C4-a was exposed to ANDV in
Villa La Angostura. In conclusion, C4 showed 2 links of
the same chain of transmission. Notably, short or long peri-
ods between patients’onset of illness probably correspond
to clusters with a common source of infection (C2) or to
the occurrence of human transmission (C1 and C4) (Figure
2). The identical viral sequence in different HPS cases
might be explained by exposure to the same viral variant
within the local rodent populations, or in special situations,
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entiating between these 2 mechanisms of transmission is
not possible in a small area, as in C2 and C3. However,
geographically distant patients rarely share identical viral
sequences; in these situations, if epidemiologic relation-
ships between patients are shown, suspecting interhuman
transmission is reasonable, as in C1 and C4.
This is the first report in which a lineage other than
ANDV Sout, that is, ANDV Cent BsAs, was implicated in
person-to-person transmission. This finding is relevant
because ANDV Cent BsAs was responsible for most HPS
cases in the province of Buenos Aires (18). Furthermore,
the possibility that the other lineages can be spread by this
mechanism cannot be discarded, and such an event could
be expected in any of the 3 affected regions. A well-done
epidemiologic investigation around each case is essential
to accurately establish the mechanism of infection. The
incubation period was 15 days for C4-b, and ranged from
24 to 26 days for C1-s and 18 to 22 days for C4-c.
However, the oldest son of C1-f did not become infected,
and taking into account that C1-s rested with C1-f in the
same bed during the end of the prodromal phase, we spec-
ulate that close and prolonged contact is necessary to pro-
duce the infection. In C4, a unique close contact was
established between 2 previously unknown persons, C4-a
and C4-b, while C4-a exhibited early clinical manifesta-
tions of respiratory disease. In this event, the unique route
of transmission was by means of small-particle infectious
saliva or respiratory aerosols during the close contact
between both persons, since C4-b was the only passenger
of the bus in whom the illness developed. Recent experi-
mental studies with sigmodontine rodents hosting ANDV
investigated the hypothesis that saliva was one of the
sources of infection within reservoir populations (19). 
In summary, virus transmission from one person to
another likely occurs during the prodromal phase or short-
ly after it ends. Previously published reports of person-to-
person transmission did not provide details of clinical
manifestation at the moment of contact, but several infec-
tions occurred while some HPS patients were initially hos-
pitalized; other patients contracted the infection after being
in contact with a recently symptomatic case-patient (12).
Current evidence indicates that casual contacts with a per-
son in early stages of HPS are not risky, but special consid-
eration should be given to contacts with case-patients that
occurred in confined places such as within vehicles or
some work environments.
Since interhuman transmission of ANDV occurred in
Argentina in 1996, the major question that clinicians have
been facing is what to do about personal protection and
patient isolation. The answer to physicians likely to
encounter HPS patients is to follow the recommended
universal precautions. However, the findings presented
here suggest that the most probable period of virus spread
would be during the days before medical attention is
sought. For this reason, the family or those who had close
contact with an HPS patient during the prodromal phase
seem to have more risk of interhuman infection than do cli-
nicians. In the management of contacts of HPS cases
caused by ANDV, epidemiologists usually give more rele-
vance to serologic tests than to clinical surveillance.
Whether serologic tests on specimens from asymptomatic
contacts are worthwhile should be determined. Such
results are usually misinterpreted since a negative serolog-
ic test result does not mean that the contact could not be
incubating the infection, and a few days later, HPS symp-
toms could develop. This negative serologic result usually
leads to delay in medical consultation. In our opinion, a
strict clinical surveillance would be more valuable: con-
tacts of HPS patients need to be monitored and advised to
immediately look for medical evaluation as soon as fever
or any other prodromal symptom develops. In this circum-
stance, a fast laboratory diagnosis is essential so virus
spread can be avoided and early intensive care and treat-
ment initiated. Patients with a confirmed diagnosis should
be transferred to a unit skilled in intensive cardiopul-
monary care. A previous study suggests that the earlier a
patient is hospitalized, the higher the probability of sur-
vival (20). Unfortunately, effective vaccines, immunother-
apeutic agents, and antiviral drugs for the prophylaxis or
treatment of hantaviral infections are not available (21);
thus far, results have been inconclusive regarding the use-
fulness of intravenous ribavirin in treating HPS (22).
Further studies will be necessary to understand more
about this rare mechanism of virus spread. More informa-
tion of virus variability of all the ANDV lineages will also
help differentiate an instance of common rodent exposure
from a new event of person-to-person transmission, espe-
cially in patients with a travel history.
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